Kaoru Hattori

Kaoru Hattori

Auto-generated profile, based on publicly available information

Kaoru Hattori

Department of Integrative Bioscience and Biomedical Engineering, Graduate School of Advanced Science and Engineering Waseda University Tokyo Japan

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2001 in The Japanese Journal of Pharmacology
Verified
Journal Article
Open access
MRMamunur Rashid
Mamunur Rashid
MWMasatomo Watanabe
Masatomo Watanabe
MNMikio Nakazawa
Mikio Nakazawa
TNTakashi Nakamura
Takashi Nakamura
KHKaoru Hattori
Kaoru Hattori
TNTakafumi Nagatomo
Takafumi Nagatomo
This study investigated the binding affinities of a newly synthesized 5-HT2 antagonist, AT-1015 (N-[2-[4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-piperidino]ethyl]-1-formyl-4-piperidinecarboxamide monohydrochloride monohydrate) for [3H]ketanserin bindings to 5-HT2 receptors in the rabbit cerebral cortex membranes using the radioligand binding assay method. The affinity of this compound was also compared with other 5-HT2-selective antagonists such as ketanserin, sarpogrelate, cyproheptadine and ritanserin, and the results showed that AT-1015 has a high pKi value for the 5-HT2 receptor. The rank order of these antagonists are: ritanserin > ketanserin approximately equal to AT-1015 > cyproheptadine approximately equal to sarpogrelate. We also evaluated the dissociation ability (slow or rapid) of AT-1015 in the rabbit cerebral cortex membrane and compared it with other 5-HT2 antagonists using the radioligand binding assay method. The blockade of [3H]ketanserin binding sites in the rabbit cerebral cortex induced by ketanserin and sarpogrelate was readily reversed by washing, whereas the inhibition by AT-1015, cyproheptadine and ritanserin was not readily reversed by washing. The % of control after washing are 76.10% and 49.55% for AT-1015 at 10(-7.5) and 10(-7.0) M, 67.32% and 50.17% for cyproheptadine at 10(7.5) and 10(-7.0) M, and 72.38% and 39.80% for ritanserin at 10(-9.5) and 10(-9.0) M concentrations, respectively. Thus, these findings suggest that AT-1015 has antagonistic properties towards the 5-HT2 receptor and also shows that AT-1015 slowly dissociates from the 5-HT2 receptor, whereas, ketanserin and sarpogrelate dissociate rapidly from the 5-HT2 receptor, which do not correlate with their affinity.

16 September 2021 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
PDF file
KHKaoru Hattori
Kaoru Hattori
MTMimiko Tabata
Mimiko Tabata
TNTohru Nojiri
Tohru Nojiri
AKAtsushi Kurata
Atsushi Kurata
Background: Aortic valve involvement is rare in patients with Behçet’ s disease (BD); however, recurrent prosthetic valve detachment after valve surgery has frequently been reported. We report a rare case of Behçet’s aortitis involving the aortic valve, mimicking active infective endocarditis (IE) with perivalvular abscess. Case summary: A 16-year-old boy, with an unknown case of BD, presented with pyrexia of unknown origin, severe aortic valve regurgitation, vegetation, and perivalvular abscess in the aortic valve. All cultures tested negative for microorganisms. As we suspected IE, aortic valve replacement was performed. After the initial surgery, recurrent prosthetic valve detachment and pseudoaneurysm formation occurred, which resulted in the diagnosis of BD. The patient underwent a modified Bentall procedure, in which the valve conduit was proximally sutured to the left ventricular outflow tract instead of the aortic annulus. Immunosuppressive therapy was initiated on the 10th postoperative day. His condition became stable, and additional surgery was not required. Discussion: The echocardiographic findings of Behçet’s aortitis involving the aortic valve resemble those of aortic valve IE. Modified Bentall procedure, combined with effective immunosuppressive therapy, may be useful in preventing prosthetic valve detachment.

2 September 2025 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
KHKaoru Hattori
Kaoru Hattori
NNNatsuki Nakama
Natsuki Nakama
JTJumpei Takada
Jumpei Takada
MNMichinobu Nagao
Michinobu Nagao
YGYasuhiro Goto
Yasuhiro Goto
KIKiyotaka Iwasaki
Kiyotaka Iwasaki
Purpose: This study investigated the effect of bicuspid aortic valve (BAV) morphology and ascending aortic curvature (AAAc) bending angles on aortic hemodynamics, focusing on transvalvular jets and secondary helical flows that contribute to systolic hemodynamic stress linked to aortic complications. Methods: Using an MRI‐compatible pulsatile flow and pressure system, 24 configurations involving six aortic valves (three Type 1 asymmetric BAVs, two Type 0 symmetric BAVs, and one tricuspid aortic valve [TAV]) across four ascending aortic morphologies—two diameters (30 mm and 40 mm) and two AAAc angles (130° and 109°)—were analyzed through four‐dimensional‐flow MRI measurements. Results: Three Type 1 BAVs displayed highly deviated transvalvular jets directed toward the aortic wall on the side of the nonfused cusp. Particularly, the right‐noncoronary and left‐noncoronary cusp fusion phenotypes exhibited markedly eccentric secondary helical flows, thereby increasing hemodynamic stress on the ascending aortic wall. A narrower AAAc further amplified these effects by elevating jet velocity and circulation. Conversely, Type 0 BAVs and TAV were suggested to have lower hemodynamic forces, characterized by less‐deviated jets and reduced secondary helical flow eccentricity. Aortic dilation, while enhancing secondary flow circulation, appeared to reduce eccentricity, suggesting a compensatory mechanism in response to altered hemodynamics. Conclusion: The combination of the position of the nonfused cusp and AAAc emerges as a critical determinant of secondary helical flow eccentricity and circulation during peak‐to‐late systole. The risk assessment based on these hemodynamic parameters offers a novel strategy for identifying individuals at elevated risk of future aortic events.